Clinical characteristics and outcomes of adenovirus infection of the urinary tract after renal transplantation

Transplant Infectious Disease

Volumn 18, Issue 2, 2016, Pages 234-239

  Nanmoku, Koji ^a   Ishikawa, N ^a   Kurosawa, A ^a   Shimizu, T ^a   Kimura, T ^a   Miki, A ^a   Sakuma, Y ^a   Yagisawa, T ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute tubulointerstitial nephritis; Ganciclovir; Human adenovirus; Renal transplantation; Urinary tract infection

Indexed keywords

CREATININE; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ANTIVIRUS AGENT;

ADENOVIRUS INFECTION; ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD GROUP ABO SYSTEM; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CYSTOSCOPY; DISEASE DURATION; DISEASE EXACERBATION; DYSURIA; FEMALE; FEVER; GRAFT RECIPIENT; HEMATURIA; HUMAN; INFECTION CONTROL; INTERSTITIAL NEPHRITIS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; URINARY TRACT INFECTION; URINE CYTOLOGY; VIREMIA; ADVERSE EFFECTS; COMPLICATION; GRAFT REJECTION; HUMAN ADENOVIRUS C; HUMAN ADENOVIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; VIROLOGY;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADULT; ANTIVIRAL AGENTS; FEMALE; GANCICLOVIR; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; URINARY TRACT INFECTIONS;

EID: 84963704184     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12519     Document Type: Article

References (17)

1. Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev 2014; 27 (3): 441-462.
2. Echavarría M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 2008; 21 (4): 704-715.
3. Yagisawa T, Nakada T, Takahashi K, Toma H, Ota K, Yaguchi H. Acute hemorrhagic cystitis caused by adenovirus after kidney transplantation. Urol Int 1995; 54 (3): 142-146.
4. Sujeet K, Vasudev B, Desai P, et al. Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient. Transpl Infect Dis 2011; 13 (2): 174-177.
5. Kozlowski T, Nickeleit V, Andreoni K. Donor-transmitted adenovirus infection causing kidney allograft nephritis and graft loss. Transpl Infect Dis 2011; 13 (2): 168-173.
6. Komiya T, Goto N, Takeda A, et al. A case of acute rejection with adenovirus infection after ABO-incompatible kidney transplantation. Clin Transplant 2009; 23 (Suppl 20): 27-30.
7. Watcharananan SP, Avery R, Ingsathit A, et al. Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery. Am J Transplant 2011; 11 (6): 1308-1314.
8. Lion T, Kosulin K, Landlinger C, et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010; 24 (4): 706-714.
9. Hoffman JA. Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant 2009; 14 (6): 625-633.
10. Florescu MC, Miles CD, Florescu DF. What do we know about adenovirus in renal transplantation? Nephrol Dial Transplant 2013; 28 (8): 2003-2010.
11. Asim M, Chong-Lopez A, Nickeleit V. Adenovirus infection of a renal allograft. Am J Kidney Dis 2003; 41 (3): 696-701.
12. Saquib R, Melton LB, Chandrakantan A, et al. Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin. Transpl Infect Dis 2010; 12 (1): 77-83.
13. Parasuraman R, Zhang PL, Samarapungavan D, Rocher L, Koffron A. Severe necrotizing adenovirus tubulointerstitial nephritis in a kidney transplant recipient. Case Rep Transplant 2013; 2013: 969186.
14. Wreghitt TG, Gray JJ, Ward KN, et al. Disseminated adenovirus infection after liver transplantation and its possible treatment with ganciclovir. J Infect 1989; 19 (1): 88-89.
15. Chen FE, Liang RH, Lo JY, Yuen KY, Chan TK, Peiris M. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplant 1997; 20 (11): 997-999.
16. Morfin F, Dupuis-Girod S, Mundweiler S, et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 2005; 10 (2): 225-229.
17. Florescu DF, Pergam SA, Neely MN, et al. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant 2012; 18 (5): 731-738.